Sanofi's Lantus insulin injection will see its price cut by 78%, the company announced Thursday. The out-of-pocket cost for all patients will be $35 for a monthly supply.

Sanofi is the latest drug company to lower the price of insulin for people with diabetes. ... Sanofi said it will cut the price of Lantus by 78% and short-acting Apidra by 70% as of Jan. 1, 2024.

Facing pressure to curb diabetes-treatment costs, Eli Lilly & Co. announced on March 1 that it is slashing insulin prices and immediately capping the out-of-pocket cost of all of its insulins at ...

Eli Lilly & Co.’s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts ...

Sanofi plans to take a 78% list-price reduction on Lantus, the company’s most widely used insulin in the U.S., and a 70% cut on its Apidra product starting in January 2024, the company said ...

Eli Lilly and Co. reported more successful late-stage trials for a unique insulin it hopes to put on the market in the next 18 months. ... the Lilly insulin would compete with Lantus, ...

Mylan is marketing a long-acting version of the best-selling Lantus insulin — which the company named Semglee — for adults with Type 2 diabetes, and adults and children with Type 1 diabetes.

TRENTON, N.J. — A less-expensive version of the world’s top-selling insulin, Sanofi’s Lantus, could go on sale in the U.S. late next year.

The company makes $15 million every day selling this type of insulin. As shown in a new report from I-MAK, the organization I help direct, the price of Lantus jumped 18 percent each year from 2012 ...

Eli Lilly & Co. shares fell as much as 3% after Sen. Bernie Sanders tweeted about the company's Lantus insulin drug. Sanders said "it makes no sense that the same drug that costs $70 in France ...

The French drugmaker said Monday it settled a lawsuit over patents for Lantus SoloStar, its once-daily insulin in a pen-like injector. The settlement allows rivals Eli Lilly and Co. and German ...